Cargando…
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment
Junctional adhesion molecule-A (JAM-A), expressed on the surface of myeloid cells, is required for extravasation at sites of inflammation and may also modulate myeloid cell activation. Infiltration of myeloid cells is a common feature of tumors that drives disease progression, but the function of JA...
Autores principales: | Kiss, Máté, Lebegge, Els, Murgaski, Aleksandar, Van Damme, Helena, Kancheva, Daliya, Brughmans, Jan, Scheyltjens, Isabelle, Talebi, Ali, Awad, Robin Maximilian, Elkrim, Yvon, Bardet, Pauline M. R., Arnouk, Sana M., Goyvaerts, Cleo, Swinnen, Johan, Nana, Frank Aboubakar, Van Ginderachter, Jo A., Laoui, Damya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751033/ https://www.ncbi.nlm.nih.gov/pubmed/36531986 http://dx.doi.org/10.3389/fimmu.2022.1003975 |
Ejemplares similares
-
Flt3L therapy increases the abundance of Treg-promoting CCR7(+) cDCs in preclinical cancer models
por: Clappaert, Emile J., et al.
Publicado: (2023) -
Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
por: Van Damme, Helena, et al.
Publicado: (2021) -
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
por: Murgaski, Aleksandar, et al.
Publicado: (2022) -
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery
por: Murgaski, Aleksandar, et al.
Publicado: (2019) -
Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
por: Clappaert, Emile J., et al.
Publicado: (2018)